julie r. gralow, md: swog so226 trial and bisphosphonates update
Published 12 years ago • 1.2K plays • Length 12:27Download video MP4
Download video MP3
Similar videos
-
2:40
dr. julie gralow discusses the swog s0500 trial
-
10:31
julie r. gralow, md: the atlas trial. tamoxifen for five years or ten years?
-
7:42
julie r. gralow, md: new endocrine therapy for metastatic breast cancer
-
3:34
julie gralow, md, provides details on the swog s0226 findings presented at sabcs 2020
-
1:15
dr. gralow discusses toxicities experienced in the swog s0307 trial
-
12:30
lose weight by fixing this little gland
-
4:26
semilobar holoprosencephaly- classic
-
1:19:16
new perspectives on menopausal hormones and heart disease
-
2:01
dr. gralow on the use of bisphosphonates in early-stage breast cancer
-
6:03
julie r. gralow, md: blood clotting issues and tamoxifen
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
8:27
julie r. gralow, md: cognitive function and breast cancer
-
1:56
dr. gralow on future research into bisphosphonates in breast cancer
-
5:10
the azure trial: what's next?
-
1:13
dr. julie gralow discusses t-dm1-induced thrombocytopenia
-
1:07
dr. julie gralow: exercise is medicine
-
0:32
julie gralow, md, on the implications of the persephone trial in early her2 breast cancer
-
1:14
julie gralow, md, shares her thoughts on new drugs in development for breast cancer.
-
0:50
julie gralow, md, discusses the monarch 1 study
-
0:44
julie gralow, md, regarding the reduction in cardiac events in the persephone study
-
2:11
dr. julie gralow on treating breast cancer bone metastases
-
0:52
dr. julie gralow discusses the antibody drug conjugate t-dm1 for breast cancer